Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach

The aim of this study was to investigate the potential of compounds from the breadfruit tree (Artocarpus altilis) as anti-breast cancer agents using in silico techniques. Material and Methods. The methods used in this study include molecular docking and ADMET (Absorption, Distribution, Metabolism, E...

Full description

Saved in:
Bibliographic Details
Main Authors: N. Su’aida, R. R. Pratama, A. Fadillah, M. Fauzi
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2025-05-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/3537
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849684921325453312
author N. Su’aida
R. R. Pratama
A. Fadillah
M. Fauzi
author_facet N. Su’aida
R. R. Pratama
A. Fadillah
M. Fauzi
author_sort N. Su’aida
collection DOAJ
description The aim of this study was to investigate the potential of compounds from the breadfruit tree (Artocarpus altilis) as anti-breast cancer agents using in silico techniques. Material and Methods. The methods used in this study include molecular docking and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) predictions to evaluate the interactions with Estrogen Receptor alpha (ERα). Results. Among the 22 compounds tested, Cycloaltisin-7 exhibited the most favorable binding affinity, with a free energy of -10.25 kcal/ mol and an inhibition constant of 30.89 nM. Additionally, Cyclocommunol and Cudraflavone B demonstrated significant binding interactions, with free energies of -9.61 kcal/mol and -9.53 kcal/mol, and inhibition constants of 90.82 nM and 103.50 nM, respectively. For comparison, the standard compound 4-Hydroxytamoxifen showed superior binding characteristics, with a free energy of -12.36 kcal/mol and an inhibition constant of 867.83 pM. ADMET predictions indicate that Cycloaltisin-7, Cyclocommunol, and Cudraflavone B meet essential drug-like criteria, suggesting their potential as viable candidates for further development as breast cancer therapeutics. Conclusion. These findings highlight Cycloaltisin-7 as a particularly promising compound, with Cyclocommunol and Cudraflavone B also showing considerable potential. This research provides valuable insights for the advancement of plant-based treatments for breast cancer.
format Article
id doaj-art-a88db70938834a16a894e1dc64f77c82
institution DOAJ
issn 1814-4861
2312-3168
language Russian
publishDate 2025-05-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-a88db70938834a16a894e1dc64f77c822025-08-20T03:23:19ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682025-05-01242687810.21294/1814-4861-2025-24-2-68-781335Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approachN. Su’aida0R. R. Pratama1A. Fadillah2M. Fauzi3Faculty of Pharmacy, Universitas Islam Kalimantan Muhammad Arsyad Al Banjari BanjarmasinFaculty of Pharmacy, Universitas Islam Kalimantan Muhammad Arsyad Al Banjari BanjarmasinFaculty of Pharmacy, Universitas Islam Kalimantan Muhammad Arsyad Al Banjari BanjarmasinFaculty of Pharmacy, Universitas Islam Kalimantan Muhammad Arsyad Al Banjari BanjarmasinThe aim of this study was to investigate the potential of compounds from the breadfruit tree (Artocarpus altilis) as anti-breast cancer agents using in silico techniques. Material and Methods. The methods used in this study include molecular docking and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) predictions to evaluate the interactions with Estrogen Receptor alpha (ERα). Results. Among the 22 compounds tested, Cycloaltisin-7 exhibited the most favorable binding affinity, with a free energy of -10.25 kcal/ mol and an inhibition constant of 30.89 nM. Additionally, Cyclocommunol and Cudraflavone B demonstrated significant binding interactions, with free energies of -9.61 kcal/mol and -9.53 kcal/mol, and inhibition constants of 90.82 nM and 103.50 nM, respectively. For comparison, the standard compound 4-Hydroxytamoxifen showed superior binding characteristics, with a free energy of -12.36 kcal/mol and an inhibition constant of 867.83 pM. ADMET predictions indicate that Cycloaltisin-7, Cyclocommunol, and Cudraflavone B meet essential drug-like criteria, suggesting their potential as viable candidates for further development as breast cancer therapeutics. Conclusion. These findings highlight Cycloaltisin-7 as a particularly promising compound, with Cyclocommunol and Cudraflavone B also showing considerable potential. This research provides valuable insights for the advancement of plant-based treatments for breast cancer.https://www.siboncoj.ru/jour/article/view/3537breadfruit plantbreast cancerestrogen alpha receptorin silico
spellingShingle N. Su’aida
R. R. Pratama
A. Fadillah
M. Fauzi
Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
Сибирский онкологический журнал
breadfruit plant
breast cancer
estrogen alpha receptor
in silico
title Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
title_full Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
title_fullStr Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
title_full_unstemmed Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
title_short Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
title_sort prediction of compounds from breadfruit plants i artocarpus altilis i as alpha estrogen receptor agonists for novel breast cancer anticancer therapy an in silico approach
topic breadfruit plant
breast cancer
estrogen alpha receptor
in silico
url https://www.siboncoj.ru/jour/article/view/3537
work_keys_str_mv AT nsuaida predictionofcompoundsfrombreadfruitplantsiartocarpusaltilisiasalphaestrogenreceptoragonistsfornovelbreastcanceranticancertherapyaninsilicoapproach
AT rrpratama predictionofcompoundsfrombreadfruitplantsiartocarpusaltilisiasalphaestrogenreceptoragonistsfornovelbreastcanceranticancertherapyaninsilicoapproach
AT afadillah predictionofcompoundsfrombreadfruitplantsiartocarpusaltilisiasalphaestrogenreceptoragonistsfornovelbreastcanceranticancertherapyaninsilicoapproach
AT mfauzi predictionofcompoundsfrombreadfruitplantsiartocarpusaltilisiasalphaestrogenreceptoragonistsfornovelbreastcanceranticancertherapyaninsilicoapproach